Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ITMCTR2026001069) titled 'Clinical efficacy evaluation of Jieyu Anshen Granules in the treatment of comorbid depression and anxiety' on April 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing University of Chinese Medicine Oriental Hospital
Condition:
Psychosomatic Diseases
Intervention:
Observation group:Routine treatment + Jieyu Anshen Granules
Recruitment Status: Not Recruiting
Phase: Others
Date of First Enrollment: 2026-06-01
Target Sample Size: Observation group:38;Control Group:38;
Countries of Recruitment:
China
To know more, visit http://itmctr.ccebtcm.org.cn/en-US/Home/ProjectVie...